Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Karyopharm Therapeutics Inc. (KPTI)

NASDAQ

$1,73

$-0,06

(-3,63%)

Previous Close: ⁦$1,79⁩

Market Closed

Karyopharm Therapeutics Inc. (KPTI) Live Price Chart

Last updated: ⁦2026-09-09 05:05:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Karyopharm Therapeutics Inc. (KPTI) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1,73, with a market capitalisation of $40,60M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,71 to $10,99. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$40,60M
Open	$1,77
Day's High	$735,08
Day's Low	$1,71
Previous Close	$1,79
Volume	964,16K
Average Volume	1,35M
P/E Ratio	--
52-Week High	$10,99
52-Week Low	$1,71
Dividend Yield	--
Earnings Date	--

Karyopharm Therapeutics Inc. (KPTI) Latest Closing Stock Price

Karyopharm Therapeutics Inc. (KPTI) last closed at $1,79 as of 2026-09-08 23:31:00, unchanged from the previous close of $1,79.

During the latest regular trading session, KPTI traded between $1,71 and $735,08, with a volume of 964,16K shares. The closing price was near the lower end and near the lower end of its 52-week range.

Karyopharm Therapeutics Inc. (KPTI) 7-Day Stock Price Change

Over the past seven days, Karyopharm Therapeutics Inc. (KPTI) moved from $1,94 to $1,73, representing a decline of 11,08% ($0,21).

The stock traded between $1,71 and $2,14 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1,18 million shares, up versus the previous seven-day period, indicating higher trading activity.

KPTI 52-Week Price Position

Position in Range: 0,2%

52W Low$1,71

52W High$10,99

KPTI is currently trading at $1,73, placing it 0,2% of the way from its 52-week low of $1,71 to its 52-week high of $10,99. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Karyopharm Therapeutics Inc. (KPTI)?

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Karyopharm Therapeutics Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	228
Exchange	NASDAQ
Company Website	https://www.karyopharm.com

How to Buy Karyopharm Therapeutics Inc. (KPTI) Stock on MEXC

Eligible investors can buy real shares of Karyopharm Therapeutics Inc. (KPTI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KPTI and Place Your Order

Open the RealStocks trading page and search for KPTI. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Karyopharm Therapeutics Inc. (KPTI) share price today?

Karyopharm Therapeutics Inc. (KPTI) is currently trading at $ 1,73, down 3,63% ($0,06) from the previous close of $ 1,79. Intraday prices update in real time during regular trading hours.

2.Is KPTI stock going up or down today?

As of 2026-09-08 23:31:00, KPTI is trading at $ 1,73, down 3,63% ($0,06) from its previous close of $ 1,79. The stock has traded between $ 1,71 and $ 735,08 during today’s regular session. Past price movements do not guarantee future results.

3.What is KPTI pre-market price?

As of 2026-09-08 23:31:00, KPTI is trading at $ 1,78 in pre-market trading, down 0,45% ($0,01) from the previous close of $ 1,79. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KPTI after-hours price?

As of 2026-09-08 23:31:00, KPTI is trading at $ 1,75 in after-hours trading, down 2,51% ($0,04) from the regular-session close of $ 1,79. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is KPTI stock trading now?

KPTI trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KPTI sit relative to its 52-week high and low?

Over the past 52 weeks, KPTI has traded between a low of $ 1,71 and a high of $ 10,99. At $ 1,73, the stock is positioned 0,2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Karyopharm Therapeutics Inc. in?

Karyopharm Therapeutics Inc. (KPTI) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Karyopharm Therapeutics Inc.'s market capitalisation and where is it listed?

Karyopharm Therapeutics Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 40,60M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KPTI valued in terms of P/E ratio and EPS?

KPTI trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Karyopharm Therapeutics Inc. pay a dividend?

Karyopharm Therapeutics Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.